These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Clinical study of the time of repeated computed tomography and replanning for patients with nasopharyngeal carcinoma. Gai X, Wei Y, Tao H, Zhu J, Li B. Oncotarget; 2017 Apr 18; 8(16):27529-27540. PubMed ID: 28404877 [Abstract] [Full Text] [Related]
6. Clinical study of the necessity of replanning before the 25th fraction during the course of intensity-modulated radiotherapy for patients with nasopharyngeal carcinoma. Wang W, Yang H, Hu W, Shan G, Ding W, Yu C, Wang B, Wang X, Xu Q. Int J Radiat Oncol Biol Phys; 2010 Jun 01; 77(2):617-21. PubMed ID: 20138444 [Abstract] [Full Text] [Related]
7. Using neoadjuvant chemotherapy and replanning intensity-modulated radiotherapy for nasopharyngeal carcinoma with intracranial invasion to protect critical normal tissue. Niu X, Chang X, Gao Y, Hu C, Kong L. Radiat Oncol; 2013 Oct 02; 8():226. PubMed ID: 24083351 [Abstract] [Full Text] [Related]
8. Effect of adaptive replanning in patients with locally advanced nasopharyngeal carcinoma treated by intensity-modulated radiotherapy: a propensity score matched analysis. Luo Y, Qin Y, Lang J. Clin Transl Oncol; 2017 Apr 02; 19(4):470-476. PubMed ID: 27718153 [Abstract] [Full Text] [Related]
9. A prospective study on volumetric and dosimetric changes during intensity-modulated radiotherapy for nasopharyngeal carcinoma patients. Cheng HC, Wu VW, Ngan RK, Tang KW, Chan CC, Wong KH, Au SK, Kwong DL. Radiother Oncol; 2012 Sep 02; 104(3):317-23. PubMed ID: 22551564 [Abstract] [Full Text] [Related]
10. Dosimetric variations of target volumes and organs at risk in nasopharyngeal carcinoma intensity-modulated radiotherapy. Zhang X, Li M, Cao J, Luo JW, Xu GZ, Gao L, Yi J, Huang X, Xiao J, Li S, Dai J. Br J Radiol; 2012 Aug 02; 85(1016):e506-13. PubMed ID: 22096217 [Abstract] [Full Text] [Related]
12. Is it necessary to repeat CT imaging and replanning during the course of intensity-modulated radiation therapy for locoregionally advanced nasopharyngeal carcinoma? Chen C, Lin X, Pan J, Fei Z, Chen L, Bai P. Jpn J Radiol; 2013 Sep 02; 31(9):593-9. PubMed ID: 23749480 [Abstract] [Full Text] [Related]
14. Volume and dosimetric variations during two-phase adaptive intensity-modulated radiotherapy for locally advanced nasopharyngeal carcinoma. Wang RH, Zhang SX, Zhou LH, Zhang GQ, Yu H, Lin XD, Lin S. Biomed Mater Eng; 2014 Sep 02; 24(1):1217-25. PubMed ID: 24212016 [Abstract] [Full Text] [Related]
15. Failure patterns of locoregional recurrence after reducing target volumes in patients with nasopharyngeal carcinoma receiving adaptive replanning during intensity-modulated radiotherapy: a single-center experience in China. Zhou X, Zhu J, Zhou C, Wang W, Ding W, Chen M, Chen K, Li S, Chen X, Yang H. Radiat Oncol; 2023 Nov 16; 18(1):190. PubMed ID: 37974274 [Abstract] [Full Text] [Related]
18. Determining appropriate timing of adaptive radiation therapy for nasopharyngeal carcinoma during intensity-modulated radiation therapy. Huang H, Lu H, Feng G, Jiang H, Chen J, Cheng J, Pang Q, Lu Z, Gu J, Peng L, Deng S, Mo Y, Wu D, Wei Y. Radiat Oncol; 2015 Sep 17; 10():192. PubMed ID: 26377685 [Abstract] [Full Text] [Related]
19. Prognostic value and predictive threshold of tumor volume for patients with locally advanced nasopharyngeal carcinoma receiving intensity-modulated radiotherapy. He YX, Wang Y, Cao PF, Shen L, Zhao YJ, Zhang ZJ, Chen DM, Yang TB, Huang XQ, Qin Z, Dai YY, Shen LF. Chin J Cancer; 2016 Nov 16; 35(1):96. PubMed ID: 27852284 [Abstract] [Full Text] [Related]